Hemostemix Announces the Appointment of Dr. Johannes Grillari to its Scientific Advisory Board Read More
Hemostemix Announces the Appointment of Dr. Terry Hébert, PhD, to its Scientific Advisory Board Read More
Hemostemix Announces Strategic Manufacturing Partnership with CytoImmune Therapeutics and $1,800,000 in Financing Commitments Read More
Hemostemix Announces Dr. Giannetti and Dr. Cecere as Co-Lead Medical Consultants, Cardiovascular Clinical Trials Read More
HEMOSTEMIX ANNOUNCES THE FIRST TRANCHE CLOSING OF $1.8M OF ITS RECENTLY ANNOUNCED PRIVATE PLACEMENT Read More
Hemostemix Announces the Incorporation of Hemostemix Quebec Inc. and $6 Million in Grant Applications Read More
